Compare SRCE & ALMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SRCE | ALMR |
|---|---|---|
| Founded | 1863 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 2.1B |
| IPO Year | 1995 | 2026 |
| Metric | SRCE | ALMR |
|---|---|---|
| Price | $85.06 | $25.69 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 3 | 5 |
| Target Price | ★ $89.67 | $35.40 |
| AVG Volume (30 Days) | 84.5K | ★ 593.7K |
| Earning Date | 10-22-2026 | 11-03-2026 |
| Dividend Yield | ★ 2.02% | N/A |
| EPS Growth | ★ 19.59 | N/A |
| EPS | ★ 3.58 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $7.93 | $59.79 |
| Revenue Next Year | $2.93 | $39.75 |
| P/E Ratio | $23.75 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $56.89 | $21.58 |
| 52 Week High | $91.46 | $39.61 |
| Indicator | SRCE | ALMR |
|---|---|---|
| Relative Strength Index (RSI) | 45.72 | 38.76 |
| Support Level | $84.58 | $23.69 |
| Resistance Level | $87.76 | $29.06 |
| Average True Range (ATR) | 1.51 | 3.16 |
| MACD | -0.05 | -0.64 |
| Stochastic Oscillator | 45.22 | 3.79 |
1st Source Corp provides specialized financing services for construction equipment, aircraft, and vehicle types through its Specialty Finance activities. The company offers commercial, small business, agricultural, and real estate loans, along with commercial leasing, treasury management, and payment services, including Fedwires, ACH, and merchant services. It also provides Renewable Energy Financing for commercial solar projects, a full range of consumer banking products, Trust and Wealth Advisory Services, and insurance products. The company operates in the commercial banking segment, which provides commercial and consumer banking services, trust and wealth advisory services, and insurance to individual and business clients across its markets.
Alamar Biosciences Inc is a proteomics company engaged in protein detection and analysis. The company has developed its own NULISA (NUcleic Acid Linked Immuno-Sandwich Assay) technology as the foundation of its Precision Proteomics platform enabling the detection and quantification of protein biomarkers in a single sample with ultra-high sensitivity and high specificity, even from very small volumes of biofluid. The company operates in single segment and focuses on developing a good sensitive proteomic liquid biopsy platform and sells instruments, consumables, and services based on this platform to enable early detection of diseases. The products of the company includes NULISAseq Panels, NULISAqpcr Assays, and others.